UNCLASSIFIED// ROUTINE R 221850Z OCT 21 MID600051074031U FM CNO WASHINGTON DC TO NAVADMIN INFO CNO WASHINGTON DC BT UNCLAS NAVADMIN 235/21 PASS TO OFFICE CODES: INFO CNO WASHINGTON DC//DNS// MSGID/GENADMIN/CNO WASHINGTON DC// SUBJ/2021-2022 NAVY INFLUENZA VACCINATION AND REPORTING POLICY// REF/A/DOC/DOD/9JUN2014// REF/B/MEMO/DHA/6025.34 // REF/C/DOC/32 CFR PART 199.21/1DEC2016// REF/D/BUMENDINST 6230.15B REF/E/MORBIDITY AND MORTALITY WEEKLY REPORT (MMWR) REF/F/DOD/DHA IPM/20-004// NARR/REF A IS THE DODI 6025.19 INDIVIDUAL MEDICAL READINESS. REF B IS THE DEFENSE HEALTH AGENCY PROCEDURAL INSTRUCTION 6025.34 GUIDANCE FOR THE DOD INFLUENZA VACCINATION PROGRAM (IVP). REF C IS 32 CFR PART 199.21, CIVILIAN HEALTH AND MEDICAL PROGRAM OF THE UNIFORMED SERVICES (CHAMPUS)/TRICARE: TRICARE PHARMACY BENEFITS PROGRAM. REF D IS DOD INSTRUCTION ADRESSING IMMUNIZATIONS AND CHEMOPROPHYLAXIS FOR THE PREVENTION OF INFECTIOUS DISEASES. REF E IS A WEEKLY MMWR REPORT PROVIDED BY THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). REF F IS THE DHA IPM 20-004 DEPARTMENT OF DEFENSE CORONAVIIRUS DISEASE 2019 VACCINATION PROGRAM IMPLEMENTATION.// POC/CDR PETER SEGUIN/FALLS CHURCH VA/ (703) 681-9474/ EMAIL: PETER.G.SEGUIN.MIL(AT)MAIL.MIL// RMKS/1. Influenza is a contagious viral respiratory illness, which can cause mild to severe illness resulting in hospitalization or death. Influenza has the potential to adversely impact Navy force readiness and mission execution. 2. Influenza Vaccination and Reporting a. Influenza Disease Prevention. Vaccination is the primary method to reduce risk of influenza by enhancing force immunity. Maintaining a clean work environment, good hygiene practices including cough/sneeze hygiene, and managing workforce exposure (e.g., social distancing, teleworking, and sick leave) are effective methods to reduce the risk of spreading influenza. b. Influenza Vaccine. Two influenza vaccines, Northern Hemisphere (NH) and Southern Hemisphere (SH) are available based on service member location and timing requirements as described in reference (b). The 2021-2022 Department of Defense (DoD) influenza season vaccine supply will be comprised of injectable vaccines. Intranasal vaccine will not be provided through the central ordering process. c. Influenza Vaccine Priority. U.S. Navy ships, operational assets, and training commands have been identified by the DoD and Department of Navy (DON) as vaccine priority groups for the 2021-2022 influenza season. d. Influenza Vaccine Ordering. The Vaccine Information and Logistics System (VIALS) is the online requisition system for seasonal influenza vaccine. VIALS tracks requisitioned vaccine electronically via Military Standard Requisitioning and Issuing Procedure (MILSTRIP) from requisition to receipt. Navy influenza vaccine is centrally funded. The VIALS Web site is common access card enabled: https://gov_only.nmlc.med.navy.mil/int_code03/vials/. e. The Naval Medical Logistics Command (NAVMEDLOGCOM) is responsible for ordering and distributing influenza vaccine for all Navy and Marine Corps activities. Additional quantities required must be coordinated with the NAVMEDLOGCOM Influenza Vaccine Manager, (240) 308-2779, DSN: 343-8054 or the Vaccine Information and Logistics System (VIALS) helpdesk at: usn.detrick.navmedlogcomftdmd.list.vialhelp@mail.mil. f. Influenza Vaccine Shipping. All ordering commands will verify their correct shipping address and point of contact information in VIALS to ensure prompt delivery. g. Influenza Vaccine Integrity (1) Temperature Monitors. All Influenza vaccine shipments include temperature monitors. All monitors must be returned to the Defense Logistics Agency Troop Support Medical (DLA-TSM) cold chain office after receipt per the included instructions and shipping materials. (a) No Alarm Status. The vaccine is ready for immediate use. (b) Alarmed Status. Do not administer vaccine. Segregate the vaccine in the refrigerator with a sign saying DO NOT USE, return temperature monitor to DLA-TSM, and await disposition. h. Influenza Vaccine Exercise. Previous influenza seasons have been used to exercise and evaluate mass vaccination scenarios. These coordinated mass vaccination campaigns provide rapid and efficient vaccinations to protect the maximum number of susceptible persons. Process improvements are made to delivery and reporting procedures based on lessons learned. Ensure masking, social distancing, group size limitations, and other appropriate precautions during any mass vaccination exercises, if undertaken. i. Vaccine Delivery. Due to vaccine demand and manufacturer limitations, complete vaccine delivery may not occur until mid-November. This delay will unintentionally test the ability to conduct rapid and complete mass vaccination exercises. j. Influenza Vaccination Compliance (1) Navy Military Personnel. The seasonal influenza vaccination is mandatory for all DoD uniformed personnel who are not medically or administratively exempt, per references (a), (b), and (d). Any refusal to receive the influenza vaccine will constitute a failure to obey a lawful order and may be punishable under the Uniform Code of Military Justice and/or result in administrative action. Prior to receiving the influenza vaccine, Navy Active and Reserve Component personnel will have access to healthcare providers to address questions or concerns with influenza vaccination. Commands must consult with the servicing Staff Judge Advocate General for additional guidance on influenza vaccination non-compliance. (2) Navy Civilian Personnel. Influenza vaccination is required for all civilian healthcare personnel as per reference (b), and is strongly encouraged for all other Navy civilian employees. (3) TRICARE Beneficiaries. Reference (c) authorizes retail network pharmacies to administer the seasonal influenza vaccine. TRICARE beneficiaries may receive influenza vaccinations with no co-pay at authorized retail network pharmacies. Beneficiaries are encouraged to contact the pharmacy regarding age restrictions as some pharmacies do not administer the influenza vaccine to individuals younger than 18 years of age. k. Influenza Vaccination Reporting. Active and Reserve Component Navy force vaccination administration compliance will be monitored via the Medical Readiness Reporting System (MRRS). Designated command personnel will access MRRS to track their personnel to ensure compliance. (1) Shore-based commands will request access to MRRS based on their unit identification code by submitting a system access authorization request available at: //mrrs.dc3n.navy.mil/mrrs (note: MRRS Web address is case sensitive). Point of contact: MRRS program office and e-mail: mrrspo(at)navy.mil (800) 537-4617 / (504) 697-7070/DSN: 647-7070. Ship- based commands may utilize Navy Medicine Online (NMO) or Shipboard Non- Tactical Automated Data Processing (SNAP) Automated Medical System (SAMS) to populate MRRS. (2) Commands must ensure that documentation of influenza vaccine administration is coded to accurately reflect the type of vaccine given. (3) Afloat units will enter influenza immunizations into the Shipboard Automated Medical System/Theater Medical Information Program Maritime (TMIP-M) for subsequent transfer to MRRS. (4) All personnel who receive the vaccination from a retail network pharmacy must provide documentation of vaccination no later than the next workday for Active Component or within 7 days for Reserve Component to ensure compliance is appropriately recorded in their electronic health records and MRRS. (5) Vaccination Timeline (a) Due to the risk of infection transmission within the unit and impact on operations, it is imperative that the vaccine be given with minimal delay as possible. Active duty units have 72 hours (three business working days) following receipt of the vaccine to administer and document the vaccine. The 72-hour requirement begins immediately only if the temperature monitor is in no alarm status upon receipt; if in alarmed status the timed requirement begins once/if the vaccine is cleared for use by DLA-TSM. If the 72 hour requirement cannot be met, unit situation reports will be submitted to the respective Immediate Superior in Command and Type Commanders. Situation reports are not required if the temperature monitor is in alarmed status and the unit is awaiting disposition from DLA-TSM. (b) As Reserve Component Command schedules vary, NAVMEDLOGCOM and DLA-TSM will coordinate to make every effort for the vaccine to arrive the week of a drill weekend. Units have 30 days following receipt of the vaccine to document, administer, and report vaccination if the temperature monitor is in a no alarm status. If in alarmed status, the timed requirement begins once/if the vaccine is cleared for use by DLA-TSM. (6) Per paragraph 2.i, uniformed member compliance must be tracked in MRRS. If desired, installations and medical treatment facilities (MTF) may also use the Navy Family Accountability and Assessment System (NFAAS) to conduct a Pandemic Influenza response exercise in conjunction with the seasonal influenza vaccine program. l. U.S. Navy Goals and Performance Standards (1) To ensure force medical readiness before peak influenza season, all Navy operational units and Navy Medical Readiness and Training Command/Units (NMRTC/U) will administer the 2021-2022 influenza vaccination to exceed the 90 percent vaccination goal by 15 December 2021 for Active and Reserve Components. Complete vaccine access will be provided for all Navy family (includes dependents, other beneficiaries, and DON civilians). Active coordination between command leadership, public affairs officers, and medical personnel is necessary to achieve success. (2) Influenza Vaccination Performance Standards. The following goals will be monitored: (a) Navy VIALS reports 100 percent of shipped vaccine received onboard by fleet and Navy units by 1 December 2021. (b) MRRS reports 90 percent of Active and Reserve Component vaccinated by 15 December 2021. Commands will coordinate with the servicing MTF to align command-wide vaccinations with Navy vaccination goals. Medical personnel at servicing MTFs will promptly report vaccinations in MRRS. m. Vaccine administration and Coronavirus Disease 2019 (COVID-19) (1) There is no current contraindication for administration of the influenza vaccination during the COVID-19 pandemic and every effort should be made to deliver the flu vaccine as quickly as possible to eligible Service members. (2) If a SARS-CoV-2 vaccine is available during the seasonal influenza vaccination period, commands will follow instructions from the CDC and per reference (f). 3. Released by Mr. Andrew S. Haeuptle, Director, Navy Staff.// BT #0001 NNNN UNCLASSIFIED//